Calculated based on number of publications stored in Pure and citations from Scopus
20102024

Research activity per year

Network

R. Kurzrock

  • University of Texas M.D. Anderson Cancer Center
  • Department of Hematology
  • Texas Children's Hospital
  • Box 0422
  • Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
  • Box 302
  • Unit 455
  • Universityof Texas M. D. Anderson Cancer Center
  • M.D. Anderson Cancer Center
  • University of Texas at Austin
  • University of Texas, M.D. Anderson Cancer Center
  • Moores Cancer Center-University of California San Diego
  • UT M.D. Anderson Cancer Cent.
  • Division of Hematology-Oncology, UC San Diego Moores Cancer Center
  • The University of Texas MD Anderson Cancer Center
  • Phase I Program
  • Univ. TX M.D. Anderson Cancer Ctr.
  • Univ. Texas M. D. Anderson Cancer C.
  • U.T. M.D. Anderson Cancer Center
  • Univ. Texas M.D. Anderson Cancer C.
  • University of California San Diego
  • Box # 302
  • Unit 422
  • Box 422
  • Division of Hematology and Oncology, Center for Personalized Cancer Therapy, University of California San Diego Moores Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Program)
  • Univesity of Texas
  • M. D. Anderson Cancer Center
  • University of Texas Health Science Center at Houston
  • Clinical Immunology and Biological Therapy M.D. Anderson Cancer Center Houston
  • Department of Investigational Cancer Therapeutics, University of Texas, M. D. Anderson Cancer Center
  • Tumor Institute
  • Univ of Texas, MD Anderson Canc Ctr
  • Bristol-Myers Squibb
  • Dana-Farber Cancer Institute
  • UC San Diego Moores Cancer Center
  • University of Texas MD Anderson Cancer Center
  • UT-M. D. Anderson Cancer Center
  • University of California at San Diego
  • Repligen Corporation
  • Johnson and Johnson Pharmaceutical Research and Development
  • the University of Texas M.D. Anderson Hospital
  • U. T. M. D. Anderson Cancer Center
  • The University of Texas, M.D. Anderson Cancer Center
  • The University of Texas M.D. Anderson Cancer Center
  • Exelixis
  • Box 61
  • Drexel University
  • University of Texas Graduate School of Biomedical Sciences Houston
  • Cancer Center, Box 41
  • Unit 0455
  • Moores Cancer Center - University of California San Diego
  • FC8.2057
  • A Phase I Program
  • M.D. Anderson Hospital
  • Anderson Hospital
  • Dept. Hematol., Clin. Immunol., B.
  • Worldwide Innovative Network in Personalized Cancer Medicine
  • University of Texas MD Anderson Cancer Center
  • UC San Diego Moores Cancer Center
  • University of Tübingen
  • Universidade Estadual de Campinas
  • American Society of Clinical Oncology
  • Department of Clinical Immunology and Biological Therapy
  • Clinical Immunology
  • University of Vienna
  • The University of Chicago
  • Johns Hopkins University
  • Fox Chase Cancer Center
  • Memorial Sloan-Kettering Cancer Center
  • Shanghai Jiao Tong University
  • Rambam Health Care Campus Israel
  • Tel Hashomer Hospital
  • Center for Personalized Therapy Clinical Trials Office
  • Houston Clinical Trials
  • University of California Office of the President
  • Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
  • UCSD Moores Cancer Center
  • University of California at San Diego Moores Cancer Center
  • Division of Hematology and Oncology
  • University of San Diego
  • UCSD Moores Cancer Center
  • Center for Personalized Cancer Therapy
  • UC San Diego Medical Center
  • Johnson & Johnson
  • Department of Hematology
  • Department of Bioimmunotherapy
  • Department of Medicine
  • Division of Hematology and Oncology
  • Moores Cancer Center
  • Department of Molecular Oncology
  • Departments of Clinical Immunology and Biological Therapy
  • Center for Personalized Therapy and Clinical Trials Office
  • Phase I Program
  • Center for Personalized Cancer Therapy
  • Experimental Therapeutics Program
  • Moores Cancer Center
  • Department of Investigational Cancer Therapeutics
  • Department of Leukemia
  • Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
  • Center for Personalized Cancer Therapy and Division of Hematology and Oncology
  • Department of Internal Medicine
  • Department of Medicine
  • Department of Breast Medical Oncology
  • The Departments of Clinical Investigation
  • Department of Leukemia
  • Phase I Program, Department of Investigational Cancer Therapeutics
  • Department of Medicine
  • Department of Cell Biology
  • Center for Personalized Therapy and Clinical Trials
  • Department of Gastrointestinal Medical Oncology
  • Department of Hematology and Bone Marrow Transplantation
  • Division of Hematology and Oncology
  • Department of Experimental Therapeutics
  • Cell Growth Regulation Laboratory
  • Department of Medical Oncology
  • Division of Hematology-Oncology
  • Moores Cancer Center
  • Departments of Medical Ontology
  • UC San Diego
  • Division of Hematology and Oncology
  • Center for Personalized Cancer Therapy and Division of Hematology and Oncology
  • Clinical Center for Targeted Therapy
  • Phase 1 Program
  • Department of Bioimmunotheraphy
  • Department of Clinical Investigations
  • Department of Bioimmunotherapy
  • Dpt. Clin. Immun./Biol. Therap
  • Section of Bone Marrow Transplantation
  • Department of Cancer Medicine
  • Depts. of Leukemia, Biostatistics and Applied Mathematics, Lymphoma/Myeloma, and Hematopathology
  • Departments of Leukemia and Bioimmunotherapy
  • Department of Biologic Studies
  • Departments of Neurosurgery and Hematopathology
  • Dept. of Clinical Investigations
  • Departments of Internal Medicine I and Nuclear Medicine
  • Dept. Clin. Immun./Biol. Ther.
  • Department of Clinical Investigation
  • Department of Oncology
  • M.D. Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics
  • Department of Experimental Therapeutics
  • Departments of Experimental Therapeutics
  • Department of Hematology and Oncology
  • Center for Personalized Cancer Therapy and Division of Hematology and Oncology
  • Department of Investigational Cancer Therapeutics-a Phase I
  • UC San Diego Moores
  • Center for Personalized Therapy
  • Division of Hematology/Oncology
  • Moores Cancer Center
  • Worldwide Innovative Network (WIN) Association–WIN Consortium
  • Department of Hematology/Oncology
  • University of California at Berkeley
  • Division of Hematology and Oncology
  • Repligen Corporation
  • Exelixis Inc.
  • Biological Therapy
  • Department of Clinical Immunology and Biological Therapy
  • WIN Consortium
  • University of Texas System
  • American Society of Clinical Oncology
  • WIN Consortium
  • WIN Consortium
  • Medical College of Wisconsin
  • University of Nebraska Omaha
  • Section of Leukocyte Biology
  • WIN Consortium for Precision Medicine

External person

Gerald S. Falchook

  • University of Texas MD Anderson Cancer Center
  • University of Texas, M.D. Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics, University of Texas, MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics, University of Texas MDAnderson Cancer Center
  • Clinical Trials Program
  • The University of Texas MD Anderson Cancer Center
  • Baylor College of Medicine
  • University of Texas at Austin
  • Department of Investigational Cancer Therapeutics
  • Unit 455
  • University of Texas M.D. Anderson Cancer Center
  • The University of Texas M. D. Anderson Cancer Center
  • Sarah Cannon Research Institute at Healthone
  • The University of Texas M.D. Anderson Cancer Center
  • Sarah Cannon Research Institute at HealthONE, Presbyterian/St. Luke's Medical Center
  • Institute at HealthONE
  • Sarah Cannon Research Institute at Health ONE, Presbyterian/St. Luke's Medical Center
  • Sarah Cannon Research Institute
  • FC8.2018
  • FC8.2057
  • U.T. MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Houston Clinical Trials
  • HealthOne
  • Presbyterian-St. Luke's Medical Center
  • Sarah Cannon Research Institute
  • Unit 455
  • University of California at San Diego
  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Program)
  • Sarah Cannon Research Institute at HealthONE
  • Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
  • Sarah Cannon Research
  • Center for Personalized Cancer Therapy and Division of Hematology and Oncology
  • Department of Investigational Cancer Therapeutics-a Phase I
  • Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program)
  • Drug Development Program
  • Drug Development Unit
  • HealthOne
  • Sarah Cannon Research Institute
  • Drug Development Program
  • University of Texas Health Science Center at Houston

External person

Shanequa Manuel

  • University of Texas MD Anderson Cancer Center
  • Department of Gastrointestinal Medical Oncology

External person

Goran Cabrilo

  • The MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
  • Department of Investigational Cancer Therapeutics (Phase I Program)

External person

Kenna R Mills Shaw

  • National Institutes of Health
  • University of Texas-Houston Health Science Center
  • The University of Texas - Houston Health Science Center
  • University of Texas MD Anderson Cancer Center
  • Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  • Departments of Sheikh Khalifa Nahyan Ben Zayed
  • Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  • Department of Gastrointestinal Medical Oncology
  • Cancer Genome Atlas Program Office
  • TCGA Genome Data Analysis Center
  • Institute of Personalized Cancer Therapy
  • Sheikh Khalifa Bin Zayed Al Nahyan
  • University of Texas Health Science Center at Houston

External person

S. Advani

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston
  • Georgetown University
  • Division of Pediatrics
  • Department of Gastrointestinal Medical Oncology
  • Deparment of Epidemiology
  • Department of Gastroenterology, Hepatology, and Nutrition
  • Department of Epidemiology
  • Department of Gastroenterology
  • Social and Behavioral Research Branch
  • National Institutes of Health
  • National Institutes of Health, Bethesda
  • Terasaki Foundation
  • Terasaki Institute for Biomedical Innovation

External person

Krittiya Korphaisarn

  • Mahidol University
  • University of Texas MD Anderson Cancer Center
  • Division of Medical Oncology
  • Department of Gastrointestinal Medical Oncology

External person

Saikat Chowdhury

  • University of Texas MD Anderson Cancer Center

External person

Alexandre Andrade Anjos Jácome

  • Hospital do Câncer de Barretos
  • Mater Dei Hospital
  • Department of Clinical Oncology
  • Medical Oncology Department
  • Hospital de Câncer de Barretos
  • University of Texas MD Anderson Cancer Center
  • Department of Gastrointestinal Medical Oncology
  • Medical Oncology Department
  • OncoBio Comprehensive Cancer Center
  • Oncoclinicas
  • OncoBio Comprehensive Cancer Center

External person

T. Mazard

  • University of Texas MD Anderson Cancer Center
  • Departments of Gastrointestina Medical Oncology
  • Centre régional de lutte du cancer Val d'Aurelle
  • Department of Medical Oncology
  • Department of Gastrointestinal Medical Oncology

External person

Sijin Wen

  • UT MD Anderson Cancer Center
  • M. D. Anderson Cancer Center
  • West Virginia University
  • West Virginia University Health Science Center
  • University of Texas M.D. Anderson Cancer Center
  • Universidade de São Paulo
  • Univ. TX M.D. Anderson Cancer Ctr.
  • MD Anderson Cancer Center
  • The University of Texas M.D. Anderson Cancer Center
  • Unit 1374
  • University of Texas MD Anderson Cancer Center
  • Dana-Farber Cancer Institute
  • University of Texas at Houston
  • University of Texas at Austin
  • David H. Koch Center for Applied Research of Genitourinary Cancers
  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • Quantitative Sciences Division
  • Department of Biostatistics
  • Department of Biostatistics
  • Depts. of Leukemia, Biostatistics and Applied Mathematics, Lymphoma/Myeloma, and Hematopathology
  • Department of Biostatistics
  • Department of Biostatistics
  • Department of Biostatistics
  • Departments of Neurosurgery and Hematopathology
  • Departments of Biostatistics
  • Department of Biostatistics
  • School of Public Health
  • Mary Babb Randolph Cancer Center
  • Department of Genitourinary Medical Oncology
  • Department of Biostatistics
  • University of Montreal
  • Memorial Sloan-Kettering Cancer Center
  • Department of Biostatistics
  • Department of Leukemia
  • Ludwig Center for Cancer Immunotherapy
  • Department of Biostatistics
  • University of Texas Health Science Center at Houston

External person

Frank Diehl

  • Deutsches Krebsforschungszentrum
  • Deutches Krebsforschungszentrum
  • Sysmex Inostics
  • German Cancer Research Center
  • Division of Applied Functional Genomics
  • Division of Functional Genome Analysis
  • Sysmex Corporation

External person

Richard B. Lanman

  • Guardant Health
  • Guardant Health, Inc.
  • Inc.

External person

Philipp Angenendt

  • Johns Hopkins University
  • Sysmex Inostics
  • University of Texas MD Anderson Cancer Center
  • Sol Goldman Pancreatic Cancer Research Center
  • Department of Gastrointestinal Medical Oncology
  • Sysmex Corporation

External person

Jane E. Rogers

  • University of Texas M.D. Anderson Cancer Center
  • The University of Texas M.D. Anderson Cancer Center
  • U.T.M.D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Departments of Pharmacy Clinical Programs
  • Departments of Pharmacy
  • Pharmacy Clinical Programs
  • Department of Pharmacy Clinical Programs
  • Department of Clinical Pharmacy
  • Department of Gastrointestinal Medical Oncology
  • Department of Clinical Pharmacy Services
  • Department of Pharmacy
  • Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
  • Clinical Pharmacy Section
  • University of Texas Health Science Center at Houston
  • U.T. M.D. Anderson Cancer Center Pharmacy Clinical Programs

External person

Veronica R. Holley

  • The MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
  • Department of Investigational Cancer Therapeutics (Phase I Program)
  • University of Texas Health Science Center at Houston

External person

Kevin B. Kim

  • California Pacific Medical Center
  • Melanoma Clinical Research Program
  • University of Texas MD Anderson Cancer Center
  • Melanoma Clinical Research Program
  • University of Texas Health Science Center at Houston
  • The University of Texas MD Anderson Cancer Center

External person

Yue Gu

  • University of Texas MD Anderson Cancer Center

External person

Daniele Lorenzini

  • University of Texas Health Science Center at Houston
  • IRCCS Fondazione Istituto Nazionale per lo studio e la cura dei tumori - Milano
  • University of Texas MD Anderson Cancer Center

External person

R. Pisanic

  • Johns Hopkins University
  • Institute for NanoBioTechnology
  • Break Through Cancer

External person

Liana Adam

  • The University of Texas M. D. Anderson Cancer Center
  • University of Texas M.D. Anderson Cancer Center
  • U.T. M.D. Anderson Cancer Center
  • Univ. Texas M.D. Anderson Cancer Ctr
  • Univ. TX M.D. Anderson Cancer Ctr.
  • UT MD Anderson Cancer Center
  • Univ. of Texas M.D. Anderson C.
  • Univ. of TX M.D. Anderson Can. Ctr.
  • Univ. Texas M.D. Anderson Cancer C.
  • Unit 1373
  • Unit 173
  • M. D. Anderson
  • University of Texas MD Anderson Cancer Center
  • Cell Growth Regulation Laboratory
  • Department of Cancer Biology
  • Department of Urology
  • Department of Molecular and Cellular Oncology
  • Department of Urology
  • Departments of Bioinformatics
  • Department of Urology
  • Cell Growth Regulation Laboratory
  • Department of Urology
  • M.D. Anderson Cancer Center
  • Dept. of Clinical Investigations
  • Department of Cancer Biology
  • University of Texas Health Science Center at Houston

External person

Joann Lim

  • Department of Investigational Cancer Therapeutics
  • University of Texas MD Anderson Cancer Center
  • Pharamacy Clinical Programs
  • University of Texas Health Science Center at Houston

External person

Ganiraju C. Manyam

  • University of Texas MD Anderson Cancer Center
  • Department of Bioinformatics and Computational Biology
  • University of Texas Health Science Center at Houston

External person

K. Madwani

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Jason Timothy Henry

  • University of Texas MD Anderson Cancer Center
  • Department of Gastrointestinal Medical Oncology

External person

J. Wang

  • Johns Hopkins University

External person

Amir Mehrvarz Sarshekeh

  • University of Texas MD Anderson Cancer Center
  • Department of Gastrointestinal Medical Oncology
  • University of Texas Health Science Center at Houston

External person

Jeffrey T. Yorio

  • The University of Texas M.D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Gastrointestinal Medical Oncology
  • Hematology and Medical Oncology Fellowship Program
  • Texas Oncology
  • University of Texas Health Science Center at Houston
  • Texas Oncology

External person

Mohammad A. Zeineddine

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Nicole D. Rothschild

  • University of Texas MD Anderson Cancer Center

External person

Nilofer Azad

  • Research Bldg
  • Sidney Kimmel Cancer Center at Johns Hopkins University
  • Johns Hopkins University
  • Wake Forest University
  • American Society of Clinical Oncology
  • Medical Oncology Branch
  • Department of Oncology
  • Department of Gastrointestinal Oncology
  • Department of Medical Oncology
  • Department of Medical Oncology
  • Sidney Kimmel Cancer Center at Johns Hopkins
  • Department of Medical Oncology
  • American Society of Clinical Oncology

External person

Abdelrahman Yousef

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Kimberly Banks

  • Guardant Health
  • Guardant Health
  • Guardant Health, Inc.
  • Guardant Health
  • University of Texas MD Anderson Cancer Center
  • Department of Gastrointestinal Medical Oncology

External person

Agop Y. Bedikian

  • M. D. Anderson Hospital
  • M. D. Anderson Cancer Center
  • University of Texas M.D. Anderson Cancer Center
  • Univ. TX M.D. Anderson Cancer Ctr.
  • Box 77
  • The University of Texas M.D Anderson Hospital and Tumor Institute at Houston
  • UT MD Anderson Cancer Center
  • The University of Texas M.D. Anderson Cancer Center
  • Tumor Institute
  • Hospital Sirio-Libanes
  • M.D. Anderson Cancer Center
  • Department of Melanoma Medical Oncology
  • King Faisal Specialist Hospital and Research Section
  • Baylor College of Medicine
  • University of Texas MD Anderson Cancer Center
  • Alfaisal University
  • University of Texas at Austin
  • Laboratory Medicine and Tumor Institute
  • Department of Developmental Therapeutics
  • Department of Melanoma
  • Department of Melanotna/Sarcoma
  • Departments of Developmental Therapeutics
  • Department of Breast Medical Oncology
  • Department of Melanoma/Sarcoma and Surgical Oncology
  • Department of Medical Oncology
  • Department of Medicine
  • Department of Developmental Therapeutics and Department of Medicine
  • Department of Developmental Therapeutics and Department of Radiology
  • University of Texas Health Science Center at Houston
  • King Faisal Specialist Hospital and Research Centre

External person

Fadl Zeineddine

  • University of Texas MD Anderson Cancer Center
  • Houston Methodist
  • University of Texas Health Science Center at Houston

External person

Ibrahim Halil Sahin

  • University of Texas M.D. Anderson Cancer Center
  • Unit 426
  • The University of Texas M.D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Gastrointestinal Medical Oncology
  • Department of Experimental Therapeutics
  • University of Texas Health Science Center at Houston
  • University of South Florida
  • Emory University
  • Continuum Health Partners, Inc.

External person

E. Karunasena

  • Johns Hopkins University
  • Department of Gastrointestinal Oncology

External person

Victoria M. Raymond

  • University of Michigan School of Public Health
  • University of Michigan, Ann Arbor
  • Division of Pulmonary and Critical Care Medicine
  • Guardant Health, Inc.
  • Guardant Health
  • Medical Affairs
  • Inc.
  • Inc

External person

Amir Ali Talasaz

  • Guardant Health, Inc.
  • Administration
  • Department of Research and Bioinformatics
  • Guardant Health

External person

S. M A Kazmi

  • University of Texas Health Science Center at Houston
  • University of Texas at Austin
  • The University of Texas M.D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Internal Medicine
  • Division of Infectious Diseases
  • Division of Internal Medicine
  • Department of Gastrointestinal Medical Oncology
  • University of Texas Southwestern Medical Center

External person

Jean Pierre Issa

  • Box 61
  • Univ. TX M.D. Anderson Cancer Ctr.
  • Temple University
  • University of Texas M.D. Anderson Cancer Center
  • University of Texas Health Science Center at Houston
  • The University of Texas M.D. Anderson Cancer Center
  • Johns Hopkins Univ. Med. I.
  • UT MD Anderson Cancer Center
  • Unit 425
  • Univ. Tex. M.D. Anderson Cancer Ctr.
  • MD Anderson Cancer Center
  • University of South Florida
  • The University of Chicago
  • Univ. Texas M.D. Anderson Cancer C.
  • Roswell Park Cancer Institute
  • U. 428, 1515 Holcombe, Houston, T.
  • The Johns Hopkins University Medical Institutions
  • Box 428
  • Johns Hopkins University
  • UT M.D. Anderson Cancer Center
  • M. D. Anderson Cancer Center
  • Johns Hopkins Oncology Center
  • School of Medicine
  • Departments of Leukemia
  • University Children's Hospital
  • Univ. of Texas M. D. A. Cancer Ctr.
  • Center for Cancer Epigenetics
  • M.D. Anderson Cancer Center
  • University of Zurich
  • Fox Chase Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Division of Cancer Medicine
  • Department of Leukemia
  • Fels Institute for Cancer Research and Molecular Biology
  • Department of Leukemia
  • Department of Leukemia
  • Fels Institute for Cancer Research and Molecular Biology
  • Oncology Center
  • Fels Institute for Cancer Research and Molecular Biology
  • Center for Cancer Epigenetics
  • Departments of Experimental Therapeutics and Leukemia
  • Cancer Biology Division
  • Department of Biochemistry
  • Cancer Epigenetics Program
  • Department of Hematology and Oncology
  • Department of Leukemia
  • Fels Institute for Cancer Research
  • Departments of Leukemia, Biostatistics, Pediatrics, and Hematopathology
  • Fels Institute
  • Molecular Biology Laboratory
  • Johns Hopkins Oncology Center
  • Department of Leukemia
  • Coriell Institute for Medical Research
  • Sidney Kimmel Comprehensive Cancer Center
  • School of Medicine
  • Coriell Institute for Medical Research

External person

Amir Mehdizadeh

  • University of Texas MD Anderson Cancer Center
  • Department of Gastrointestinal Medical Oncology
  • University of Texas Southwestern Medical Center
  • University of Texas Health Science Center at Houston

External person

Muddassir Syed

  • University of Bologna
  • University of Texas MD Anderson Cancer Center

External person

Brent J. Shelton

  • University of Kentucky
  • Markey Cancer Center

External person

Jens Fritsche

  • Immatics Biotechnologies
  • Immatics Biotechnologies GmbH

External person

Michael D. Swartz

  • Unit 1340, U.T.M.D. Anderson Cancer Center
  • University of Texas M.D. Anderson Cancer Center
  • UT School of Public Health
  • University of Texas, Health Science Center at Houston
  • University of Texas Health Science Center at Houston
  • University of Texas at Austin
  • The University of Texas MD Anderson Cancer Center
  • School of Public Health
  • University of Texas MD Anderson Cancer Center
  • Department of Epidemiology
  • Department of Epidemiology
  • School of Public Health
  • Department of Epidemiology
  • Department of Biostatistics
  • Health Science Center
  • Division of Biostatistics
  • Division of Biostatistics
  • Division of Biostatistics
  • Department of Biostatistics
  • Division of Epidemiology and Disease Control
  • Department of Biostatistics and Data Science
  • Department of Biostatistics and Data Science

External person

Steffen Walter

  • Immatics Biotechnologies GmbH

External person

Limin Zhu

  • University of Texas MD Anderson Cancer Center

External person

O. Aziz

  • St. Mark's Hospital and Academic Institute
  • University College Dublin
  • The Christie NHS Foundation Trust
  • University of Manchester

External person

Jeffrey A. Moscow

  • University of Kentucky
  • Markey Cancer Center
  • Cancer Therapy Evaluation Program
  • National Institutes of Health

External person

F. L. Deaton

  • University of Texas MD Anderson Cancer Center
  • Department of Gastrointestinal Medical Oncology

External person

Delise H. Herron

  • Univ. TX M. D. Anderson Cancer Ctr.
  • University of Texas M.D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Diagnostic Radiology
  • Department of Diagnostic Imaging
  • Department of Diagnostic Radiology
  • Department of Gastrointestinal Medical Oncology
  • University of Texas Health Science Center at Houston

External person

Giovanni Nitti

  • University of Texas Health Science Center at Houston
  • University of Texas at Austin
  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
  • Department of Cancer Biology
  • Department of Urology
  • Department of Experimental Therapeutics
  • Program in Human Biology and Patient-Based Research

External person

Huei Kai Lin

  • University of Texas MD Anderson Cancer Center

External person

Allan Andresson Lima Pereira

  • University of Texas MD Anderson Cancer Center
  • Universidade de São Paulo
  • Oncology and Radiology Department
  • Department of Gastrointestinal Medical Oncology
  • Hospital Sirio-Libanes

External person

Erwin Sablon

  • Biocartis
  • Biocartis NV
  • Biocartis Group

External person

Oluwadara Coker

  • University of Texas MD Anderson Cancer Center

External person

M. Nusrat

  • University of Texas UT Health Internal Medicine Residency Program
  • University of Texas at Austin
  • University of Texas Health Science Center at Houston
  • Department of Internal Medicine
  • University of Texas MD Anderson Cancer Center
  • Department of Gastrointestinal Medical Oncology
  • Memorial Sloan-Kettering Cancer Center

External person

Vijaykumar Holla

  • University of Texas M.D. Anderson Cancer Center
  • UT MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Cancer Biology
  • Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  • Department of Cancer Biology
  • Department of Cancer Biology
  • University of Texas Health Science Center at Houston

External person

Elmer V. Bernstam

  • Univ. Texas Hlth. Sci. Ctr. Houston
  • The University of Texas Health Science Center
  • University of Texas Health Science Center
  • Medical School, The University of Texas Health Science Center
  • University of Texas School of Medicine at Houston
  • University of Texas Health Science Center at Houston
  • National Center for Cognitive Informatics and Decision Making
  • The University of Texas Medical School at Houston
  • 7000 Fannin St., Suite 600, H.
  • University of Texas-Health Science Center at Houston
  • The University of Texas Health Science Center at Houston
  • the University of Texas Health Science Center
  • University of Texas at Austin
  • University of Texas MD Anderson Cancer Center
  • Univ. Texas Hlth. Sci. Ctr. Houston
  • Department of Internal Medicine
  • School of Biomedical Informatics
  • Department of Internal Medicine
  • Department of General Internal Medicine
  • Division of General Internal Medicine
  • School of Biomedical Informatics
  • Cardiology Division
  • Center for Computational Biomedicine
  • Div. of Allerg. and Clin. Immunology
  • School of Health Information Sciences
  • The University of Texas School of Health Information Sciences Houston
  • Yale University
  • School of Health Informatics
  • Division of General Internal Medicine
  • University of Texas System

External person

Kenna R. Mills Shaw

  • University of Texas MD Anderson Cancer Center
  • Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  • Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  • Cancer Genome Atlas Program Office
  • National Institutes of Health
  • 31 Center Drive 3A20
  • Department of Gastrointestinal Medical Oncology

External person

Ann M. Bailey

  • University of Kansas
  • UT MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  • Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  • Department of Pharmacology
  • Institute of Personalized Cancer Therapy
  • Sheikh Khalifa Bin Zayed Al Nahyan
  • Hormonal Oncogenesis Laboratory, Kansas Cancer Center
  • University of Texas Health Science Center at Houston

External person

John H. Strickler

  • Duke University
  • Department of Medicine
  • University Medical Center

External person

Philip DeSimone

  • University of Kentucky
  • Nuclear Medicine Service
  • Markey Cancer Center

External person

Mohammad Fanaeian

  • University of Texas MD Anderson Cancer Center

External person

Stefania Napolitano

  • University of Texas MD Anderson Cancer Center
  • Department of Gastrointestinal Medical Oncology
  • University of Campania Luigi Vanvitelli
  • Medical Oncology

External person

Katrina Y. Glover

  • Universidade de São Paulo
  • M.D. Anderson Cancer Center
  • The University of Texas M.D. Anderson Cancer Center
  • Tyler Hematology-Oncology PA
  • University of Texas M.D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Tyler Hematology/Oncology
  • Department of Gastrointestinal Medical Oncology
  • Departments of Gastrointestinal Medical Oncology and Clinical Cancer Prevention
  • University of Texas Health Science Center at Houston

External person

Drew Goldstein

  • Palantir Technologies

External person

A. Adat

  • University of Texas MD Anderson Cancer Center

External person

Katrin Aslan

  • German Cancer Research Center
  • Department of Neurology
  • Faculty of Biosciences
  • Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology
  • Immatics Biotechnologies GmbH
  • Heidelberg University 

External person

Ryan B. Corcoran

  • Harvard University
  • Department of Medicine
  • Department of Medicine
  • Department of Medical Oncology
  • Department of Medicine
  • Department of Medicine
  • Department of Medicine
  • Gastrointestinal Unit
  • Department of Medicine
  • Department of Medicine
  • Department of Hematology/Oncology
  • Princeton University
  • Massachusetts General Hospital Cancer Center
  • Massachusetts General Hospital

External person

Yoshikuni Kawaguchi

  • The University of Tokyo
  • Hepato-Biliary-Pancreatic Surgery Division
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

M. Knafl

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Yazmin San Miguel

  • University of Texas Health Science Center at Houston
  • Abbott Laboratories

External person

Franziska Hoffgaard

  • Immatics Biotechnologies GmbH

External person

Lauren Brusco

  • Departments of Investigational Cancer Therapeutics
  • University of Texas MD Anderson Cancer Center
  • Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  • Baylor College of Medicine
  • Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  • Lester and Sue Smith Breast Center
  • Department of Molecular and Cellular Biology
  • University of Texas Health Science Center at Houston
  • Surgical Oncology

External person

Badi El Osta

  • University of Texas M.D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Emory University
  • Department of Palliative Care and Rehabilitation Medicine
  • Department of Hematology and Medical Oncology
  • University of Texas Health Science Center at Houston

External person

Andrea Muranyi

  • Ventana Medical Systems
  • F. Hoffmann-La Roche AG

External person

H. Singh

  • Immatics Biotechnologies
  • Immatics Biotechnologies GmbH
  • Immatics Biotechnologies GmbH

External person

Neal Bhutiani

  • University of Louisville
  • Division of Pediatric Surgery
  • University of Texas MD Anderson Cancer Center

External person

Dominik Maurer

  • Immatics Biotechnologies GmbH
  • Immatics Biotechnologies GmbH

External person

Hwa Young Lee

  • University of Texas MD Anderson Cancer Center
  • Department of Epidemiology
  • Cancer Prevention Training Research Program
  • University of Texas Health Science Center at Houston

External person

Allan A. Lima Pereira

  • University of Texas MD Anderson Cancer Center
  • Department of Gastrointestinal Medical Oncology
  • University of Texas Health Science Center at Houston

External person

Helen R. Moinova

  • Research Institute at University Hospitals of Cleveland
  • Case Western Reserve University
  • Case Comprehensive Cancer Center
  • Ireland Cancer Center
  • Department of Medicine

External person

Bart Claes

  • Biocartis NV
  • Biocartis
  • KU Leuven
  • Biocartis Group
  • Vesalius Research Center

External person

Henry Henderson

  • Foundation Medicine, Inc.
  • University of Texas Health Science Center at Houston

External person

Sabrina Kuttruff-Coqui

  • Immatics Biotechnologies GmbH

External person

Claudia Wagner

  • Immatics Biotechnologies GmbH

External person

Yang Ye

  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics
  • M. D. Anderson Cancer Center
  • The University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Zoe Coughlin

  • Immatics Biotechnologies GmbH

External person

Zahra A. Naini

  • University of Texas MD Anderson Cancer Center

External person

Takeo Fujii

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston
  • Department of Breast Medical Oncology
  • Department of Biostatistics
  • Department of Biostatistics
  • Health Science Center
  • University of Hawai'i at Mānoa

External person

Paul Edelkamp

  • University of Texas MD Anderson Cancer Center

External person

Sanford D. Markowitz

  • Howard Hughes Medical Institute
  • Case Western Reserve University
  • Case Western Reserve University School of Medicine
  • Johns Hopkins Oncology Center
  • The University of Chicago
  • Cancer Prevention Research Center
  • Johns Hopkins University
  • Case Western Reserve University and Case Medical Center of University Hospitals of Cleveland
  • Fred Hutchinson Cancer Research Center
  • Department of Medicine
  • Department of Medicine
  • Department of Medicine, Hematology/Oncology
  • Case Comprehensive Cancer Center
  • Department of Medicine
  • Case Comprehensive Cancer Center
  • Department of Medicine and Ireland Cancer Center
  • Ireland Cancer Center
  • Department of Medicine
  • Division of Hematology and Oncology
  • Case Comprehensive Cancer Center
  • Ireland Cancer Center
  • Cancer Prevention Research Program
  • Departments of Medicine and Genetics
  • Case Comprehensive Cancer Center
  • Howard Hughes Medical Institutes
  • Karolinska Institutet
  • Institute of Environmental Medicine

External person

David S. Lopez

  • University of Texas Health Science Center at Houston
  • University of Texas MD Anderson Cancer Center
  • Departments of Epidemiology
  • University of Texas- Houston School of Public Health
  • Deparment of Epidemiology
  • Department of Epidemiology
  • Division of Epidemiology
  • Division of Epidemiology
  • Division of Epidemiology, Human Genetics, and Environmental Sciences
  • University of Texas Medical Branch at Galveston
  • Department of Preventive Medicine and Community Health
  • UT Health McGovern Medical School

External person

Yujiro Nishioka

  • University of Texas MD Anderson Cancer Center
  • The University of Tokyo

External person

Markos Leggas

  • St. Jude Children's Res. Hospital
  • University of Kentucky
  • St. Jude Children Research Hospital
  • Markey Cancer Center
  • Department of Pharmaceutical Sciences
  • Department of Pharmaceutical Sciences

External person

Benoit Devogelaere

  • Biocartis Group
  • Cartagenia

External person

Young Uk Kim

  • University of Texas Health Science Center at Houston
  • University of Texas MD Anderson Cancer Center

External person

A. L. Stuckett

  • University of Texas MD Anderson Cancer Center

External person

Carsten Reinhardt

  • Immatics Biotechnologies GmbH

External person

Beate C. Litzenburger

  • Baylor College of Medicine
  • University of Texas MD Anderson Cancer Center
  • Houston Methodist
  • Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  • Departments of Medicine and Molecular and Cellular Biology
  • Bioinfor-matics
  • QIAGEN
  • University of Texas Health Science Center at Houston
  • RWTH Aachen University

External person

Dawne N. Shelton

  • University of Utah
  • Bio-Rad Laboratories
  • Department of Oncological Sciences
  • Huntsman Cancer Institute
  • Bio-Rad Laboratories, Inc. (MOD)

External person

John R. Eckardt

  • Center for Cancer Care and Research

External person

Eleftheria Tsakalozou

  • University of Kentucky
  • Markey Cancer Center

External person

Jorge Bellido

  • University of Texas MD Anderson Cancer Center

External person

Gabi Tarcic

  • Weizmann Institute of Science
  • The Weizmann Institute of Science
  • NovellusDx
  • NovellusDx
  • Department of Biological Regulation
  • Novellus Bio

External person

Vinay Pattalachinti

  • University of Texas MD Anderson Cancer Center
  • Univ. Texas Hlth. Sci. Ctr. S. A.

External person

George Karlin-Neumann

  • Affymetrix
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc. (MOD)
  • LGC Ltd.

External person

Jiang Zhi-Qin

  • University of Texas MD Anderson Cancer Center
  • Fudan University
  • Texas Medical Center
  • Department of Gastrointestinal Medical Oncology
  • Fudan University Shanghai Cancer Center
  • M.D. Anderson Cancer Center
  • Department of Radiation Oncology
  • Texas Medical Center
  • University of Texas Health Science Center at Houston

External person

Tian Feng

  • University of Texas MD Anderson Cancer Center
  • Department of Gastrointestinal Medical Oncology

External person

Ming Mo Hou

  • Chang Gung University
  • University of Texas MD Anderson Cancer Center
  • Division of Hematology-Oncology
  • Division of Hematology-Oncology
  • Department of Hematology and Oncology
  • University of Texas Health Science Center at Houston
  • Chang Gung Memorial Hospital

External person

James L. Abbruzzese

  • Box 92
  • University of Texas M.D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Univ. TX MD Andersen Cancer Ctr.
  • M.D. Anderson Cancer Center
  • The University of Texas M.D. Anderson Cancer Center
  • The University of Texas, M.D. Anderson Hospital and Tumor Institute at Houston
  • Univ. TX M.D. Anderson Cancer Ctr.
  • Universidade de São Paulo
  • Box 429
  • UT-M. D. Anderson Cancer Center
  • Univ. TX M. D. Anderson Cancer Ctr.
  • Pancreatic Tumor Study GroupThe University of Texas M.D. Anderson Cancer Center
  • University of Texas Health Science Center at Houston
  • M. D. Anderson Cancer Center
  • Universityof Texas M. D. Anderson Cancer Center
  • Univ. Texas M.D. Anderson Cancer C.
  • University of Texas at Austin
  • Univ. Texas-MD Anderson Cancer Ctr.
  • Texas Univ. M.D. Anderson Can. Ctr.
  • University of California at San Francisco
  • Pancreatic Cancer Study Group
  • M D Anderson Cancer Center
  • Univ. Tex. M.D. Anderson Cancer Ctr.
  • Novartis
  • NCCN
  • Univ. Texas M.D. Anderson Can. Ctr.
  • Univ. Texas, M.D. Anderson Cancer C.
  • Univ. Texas M. D. Anderson Cancer C.
  • Johnson and Johnson Pharmaceutical Research and Development
  • Univ. Texas M. D. Anderson Can. Ctr.
  • The University of Texas MD Anderson Cancer Center
  • University of Alabama
  • Box 78
  • University of Texas M. D. Aderson Cancer Center
  • The University of Texas M. D. Anderson Cancer Center at Houston
  • University of Texas M.D. Anderson Cancer Center Pancreatic Tumor Study Group
  • Unit 426
  • Box 106
  • Dept. of Gastrointest. Med. and Nutr., Univ. of Texas
  • Memorial Hermann Hospital
  • United States Food and Drug Administration
  • UT M D Anderson Cancer Center
  • Academic Medical Center
  • U.T. M.D. Anderson Cancer Center
  • UT M.D. Anderson Cancer Center
  • The University of Texas M. D. Anderson Cancer Center
  • UT MD Anderson Cancer Center
  • Emory University
  • Division of Biostatistics, University of Texas School of Public Health
  • Mansoura University
  • Gastrointestinal Medical Oncology and Digestive Diseases
  • Memorial Hermann-Texas Medical Center
  • University of Amsterdam
  • Duke Cancer Institute
  • Duke University
  • University of Texas MD Anderson Cancer Center
  • Duke Cancer Institute
  • Gastrointestinal Medical Oncology
  • National Institutes of Health
  • Chemoprevention Branch
  • University of Texas M. D. Anderson Cancer Center
  • Duke School of Medicine
  • Orlando Regional Medical Center
  • Johnson & Johnson
  • Department of Gastrointestinal Medical Oncology
  • Dept. of Gastrointest. Med. Oncology
  • Department of Medical Oncology, Division of Medicine
  • Division of Cell Therapy and Hematologica
  • Department of Medicine
  • Department of Breast Medical Oncology
  • Departments of Experimental Therapeutics and Gynecologic Medical Oncology
  • Department of Gastrointestinal Medical Oncology
  • Dept. of Gastrointest. Med. Oncology
  • Department of Medical Oncology
  • M.D. Anderson Cancer Center
  • Division of Medical Oncology
  • Dept. Gastrointest. Oncol. D.
  • MD Andersen Cancer Center
  • Gastrointest. Oncol. Digest. Dis.
  • Department of Gastrointestinal Medical Oncology
  • Department of Pathology
  • Department of Medicine/Division of Oncology
  • Dept. of Clinical Investigations
  • Department of Clinical Investigation
  • Dept. of Gastrointest. Med. O.
  • Departments of Gastrointestinal Medical Oncology and Clinical Cancer Prevention
  • Division of Medical Oncology
  • Gastrointestinal Medical Oncology
  • Department of Gastrointestinal Medical Oncology and Digestive Diseases
  • Gastrointestinal Oncol. Sec.
  • Department of Medical Oncology Division of Medicine
  • Department of Medical Oncology
  • Cell Growth Regulation Laboratory
  • Dept. of Gastro. Oncol./Digest. Dis.
  • Department of Surgical Oncology
  • Department of Clinical Investigations
  • Pancreatic Tumor Study Group
  • Department of Cell Biology
  • Division of Medical Oncology
  • Division of Medical Oncology
  • Dept. Gastrointest. Oncol. Surg. O.
  • Dept. of Gastrointest. Med. Oncology
  • Chemoprevention Branch
  • Department of Gastrointestinal Medicai Oncology
  • Department of Surgery
  • Pancreatic Tumor Study Group
  • Department of Medical Oncology
  • Department of Diagnostic Imaging
  • Department of Surgery
  • Depts. of Epidemiology, Gastrointestinal Medical Oncology, Surgical Oncology, and Radiation Oncology
  • Department of Medicine
  • Molecular Biology Laboratory
  • JLA)
  • Department of Cell Biology
  • Gastrointestinal Medical Oncology
  • Memorial Hermann Healthcare System
  • Gastroint. Oncol./Digest. Dis. Dept.
  • Departments of Medicine
  • Division of Medical Oncology
  • Department of Cancer Biology
  • Division of Medical Oncology
  • Amsterdam University Medical Center

External person

Amber M. Johnson

  • UT MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  • Institute of Personalized Cancer Therapy
  • Sheikh Khalifa Bin Zayed Al Nahyan
  • University of Texas Health Science Center at Houston

External person

Ali S. Mohamed

  • Immatics Biotechnologies GmbH

External person

Katherine Clifton

  • University of Texas MD Anderson Cancer Center
  • Department of Gastrointestinal Medical Oncology
  • University of Texas Health Science Center at Houston
  • Washington University St. Louis

External person

Imad Shureqi

  • University of Texas MD Anderson Cancer Center

External person

Amir Mehvarz Sarsashek

  • University of Texas MD Anderson Cancer Center

External person

Chetna Wathoo

  • University of Texas MD Anderson Cancer Center
  • Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  • Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  • Department of Surgical Oncology
  • University of Texas Health Science Center at Houston

External person

Nishma M. Ramzanali

  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)

External person

Thomas LaFramboise

  • Case Western Reserve University School of Medicine
  • Case Western Reserve University
  • Department of Genomics and Genome Sciences
  • Dept. of Genetics

External person

Carrie A. Cartwright

  • University of Texas MD Anderson Cancer Center
  • Department of Cancer Biology
  • Louisiana State University
  • Departments of Experimental Therapeutics
  • Cytokine Research Laboratory
  • Pharmaceutical Development Center
  • University of Texas Health Science Center at Houston

External person

Marwan G. Fakih

  • University of Michigan, Ann Arbor
  • University at Buffalo School of Medicine and Biomedical Sciences
  • Roswell Park Cancer Institute
  • City of Hope Comprehensive Cancer Center
  • SUNY Buffalo
  • City of Hope National Med Center
  • University of Pittsburgh
  • Molecular Therapeutics Drug Discovery Program
  • Department of Medicine
  • Department of Medicine
  • Department of Medicine
  • Department of Medical Oncology
  • Leukemia Service Department
  • Dept of Medical Oncology and Therapeutics Research
  • Medical Oncology
  • City of Hope Medical Center

External person

Kerstin Guenther

  • Immatics Biotechnologies GmbH

External person

Hesham M. Hassabo

  • University of Texas MD Anderson Cancer Center
  • The University of Texas M.D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Gastrointestinal Medical Oncology
  • Department of Medical Oncology
  • University of Texas Health Science Center at Houston

External person

Regina Mendrzyk

  • Immatics Biotechnologies GmbH

External person

Suebpong Tanasanvimon

  • Unit 426
  • MD Anderson Cancer Center, The University of Texas
  • University of Texas MD Anderson Cancer Center
  • Chulalongkorn University
  • Division of Hematology
  • Department of Gastroenterology, Hepatology, and Nutrition
  • Faculty of Medicine
  • Department of Gastrointestinal Medical Oncology

External person

Lucas Wong

  • Baylor Scott & White Health
  • Scott & White Memorial Hospital
  • Department of Medicine

External person

Becky Norris

  • University of Texas MD Anderson Cancer Center

External person

Linus Backert

  • Department of Immunology
  • Immatics Biotechnologies GmbH
  • University of Tübingen

External person

Ruoxi Yu

  • University of Texas MD Anderson Cancer Center

External person

Rabih Said

  • University of Texas Health Science Center at Houston
  • Department of Internal Medicine
  • The University of Texas Health Science Center at Houston
  • University of Texas at Austin
  • University of Texas MD Anderson Cancer Center
  • University of Balamand
  • Department of General Internal Medicine
  • Department of Oncology
  • Department of Internal Medicine
  • Memorial Hermann Cancer Center
  • Division of Internal Medicine-Oncology
  • Saint George Hospital University Medical Center
  • Saint George Hospital University Medical Center

External person

Fabian Richter

  • Immatics Biotechnologies GmbH

External person

Ben George

  • Medical College of Wisconsin
  • Division of Hematology and Oncology
  • Center for International Blood and Marrow Transplant Research
  • Department of Medical Oncology

External person

Jane Thomas

  • University of Texas MD Anderson Cancer Center
  • Department of Gastrointestinal Medical Oncology

External person

Rita Ort

  • University of Texas MD Anderson Cancer Center

External person

Manuel Ruh

  • Immatics Biotechnologies GmbH

External person

Joe Ensor

  • University of Texas M.D. Anderson Cancer Center
  • Department of Biostatistics, University of Texas, MD Anderson Cancer Center
  • Harvard University
  • The University of Texas M.D. Anderson Cancer Center
  • The University of Texas M. D. Anderson Cancer Center
  • Department of Biostatistics
  • University of Texas MD Anderson Cancer Center
  • Baylor College of Medicine
  • Houston Methodist
  • Melanoma Medical Oncology
  • Houston Methodist Cancer Center
  • Houston Methodist
  • Department of Biostatistics
  • Department of Biostatistics
  • Houston Methodist Cancer Center
  • Departments of Biostatistics
  • Division of Quantitative Sciences
  • Quantitative Sciences Division
  • Department of Biostatistics
  • Department of Reconstructive and Plastic Surgery, Box 62
  • Department of Quantitative Sciences
  • Department of Biostatistics
  • Houston Methodist Cancer Center
  • Department of Biostatistics
  • Department of Biostatistics
  • Department of Pathology
  • Department of Pathology
  • Department of Gastrointestinal Medical Oncology
  • Department of Biostatistics
  • Cancer Research Program
  • University of Texas Health Science Center at Houston
  • Methodist Cancer Center

External person

Susanne M. Arnold

  • University of Kentucky
  • Markey Cancer Center
  • Community and Family Medicine
  • Dartmouth College
  • Division of Cardiovascular Medicine

External person

Metha Trupti

  • University of Texas MD Anderson Cancer Center
  • Department of Pathology

External person

Toni Weinschenk

  • Immatics US
  • Immatics Biotechnologies
  • Immatics Biotechnologies GmbH
  • Oncology, Inc.

External person

Savita Bidyasar

  • M.D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • VA Medical Center
  • University of Texas Medical Branch at Galveston

External person

Mahmoud Yousef

  • University of Texas MD Anderson Cancer Center

External person

J. Barriuso

  • Royal Marsden Hospital, Sutton
  • Hospital Universitario la Paz
  • Universidad Autónoma de Madrid
  • Institute of Cancer Research
  • Drug Development Unit
  • Royal Marsden Hospital
  • Drug Development Unit
  • Royal Marsden NHS Foundation Trust
  • The Institute of Cancer Research, London
  • Hospital Universitario La Paz
  • The Christie NHS Foundation Trust
  • University of Manchester

External person

John J. Rinehart

  • University of Kentucky
  • Baylor Scott & White Health
  • Division of Hematology/Oncology
  • Markey Cancer Center

External person

Amir Alpert

  • University of Texas MD Anderson Cancer Center
  • Division of Pediatrics
  • Immatics Biotechnologies GmbH

External person

Wenhua Lang

  • University of Texas M.D. Anderson Cancer Center
  • Univ. of Florida Shands Can. Center
  • University of Texas Health Science Center at Houston
  • University of Texas MD Anderson Cancer Center
  • University of Florida
  • UT MD Anderson Cancer Center
  • Molecular Biology Laboratory
  • Department of Translational Molecular Pathology

External person

Aki Ohinata

  • The University of Texas M.D. Anderson Cancer Center
  • University of Texas M.D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Gastrointestinal Medical Oncology
  • University of Texas Southwestern Medical Center
  • University of Texas Health Science Center at Houston

External person

Shahab Ahmed

  • Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Unit 426
  • University of Texas MD Anderson Cancer Center
  • Department of Gastrointestinal Medical Oncology
  • University of Texas Health Science Center at Houston

External person

Dejana Braithwaite

  • Georgetown University
  • University of Florida

External person

Todd Crocenzi

  • Columbia River Oncology Program
  • Providence Portland Medical Center
  • Columbia River Community Clinical Oncology Program
  • Earle Chiles Cancer Center
  • Providence Portland Medical Center

External person

Kandavel Shanmugam

  • Ventana Medical Systems
  • F. Hoffmann-La Roche AG
  • Mayo Clinic Scottsdale, AZ

External person

Madeleine Strach

  • The Christie NHS Foundation Trust
  • University of Manchester
  • University of Sydney

External person

Cedrik M. Britten

  • TRON - Translational Oncology at the Univ. Medical Center of the Johannes Gutenberg Univ. Mainz
  • Leiden University
  • Ribological GmbH
  • Johannes Gutenberg University Mainz
  • Immuno-Oncology Combinations DPU, Oncology R and D, GSK
  • BioNTech RNA Pharmaceuticals GmbH
  • Department of Immunohematology and Blood Transfusion
  • Department of Medicine 2
  • Association for Cancer Immunotherapy (CIMT)
  • BioNTech AG
  • BioNTech Ag
  • Oncology R&D
  • CIMT/CIP - Association for Cancer Immunotherapy
  • working group Cancer Immunoguiding Program
  • GlaxoSmithKline
  • Immatics Biotechnologies GmbH

External person

Nikeshan Jeyakumar

  • University of Texas MD Anderson Cancer Center

External person

Nicolas Sommer

  • Genentech Incorporated

External person

Jeff Jin

  • University of Texas MD Anderson Cancer Center

External person

Victoria Higbie

  • University of Texas MD Anderson Cancer Center

External person

Norbert Hilf

  • Immatics Biotechnologies GmbH
  • Immatics Biotechnologies GmbH

External person

Shanda H. Blackmon

  • Methodist DeBakey Heart and Vascular Center
  • Baylor College of Medicine
  • Columbia University
  • Cornell University
  • New York Methodist Hospital
  • Hebrew University of Jerusalem
  • The Methodist Hospital
  • Houston Methodist Research Institute
  • Department of Surgery
  • University of Texas Health Science Center at Houston
  • Mayo Clinic Rochester, MN
  • University of Texas MD Anderson Cancer Center
  • Houston Methodist
  • Department of Thoracic and Cardiovascular Surgery
  • Department of Surgery
  • Department of Thoracic and Cardiovascular Surgery
  • Department of Surgery
  • Department of Surgery
  • Weill Medical College
  • Department of Surgery
  • Department of Cardiovascular Surgery
  • Department of Pathology
  • Department of Surgery
  • Department of Cardiovascular Surgery

External person

Xiaofei Song

  • University of Texas Health Science Center at Houston
  • University of Texas MD Anderson Cancer Center

External person

Aditya More

  • University of Texas MD Anderson Cancer Center

External person

Jitesh Kawedia

  • University of Cincinnati
  • University of Texas MD Anderson Cancer Center
  • Pharmacy Pharmacology Research
  • Department of Pharmacy Research
  • Department of Molecular Genetics, Biochemistry and Microbiology
  • Stem Cell Transplantation & Cellular Therapy Center
  • University of Texas Health Science Center at Houston

External person

Nora Sanchez

  • University of Texas MD Anderson Cancer Center
  • Department of Molecular and Cellular Oncology
  • Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  • University of Texas Health Science Center at Houston
  • Cornell University
  • Vanderbilt University
  • Department of Pharmacology

External person

Shadarra Crosby

  • University of Texas MD Anderson Cancer Center
  • Department of Gastrointestinal Medical Oncology

External person

Anna Nowak

  • Immatics Biotechnologies GmbH

External person

S. Greg Call

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Jia Zeng

  • University of Texas MD Anderson Cancer Center
  • Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  • University of Texas Health Science Center at Houston

External person

Kerry Sieger

  • Immatics Biotechnologies GmbH

External person

Kristin D. Alfaro

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

David Fuhrmann

  • Immatics Biotechnologies GmbH

External person

Shehara Mendis

  • Division of Medical Oncology
  • BC Cancer Centre
  • University of British Columbia
  • BC Cancer

External person

Jennifer Beck

  • University of Texas MD Anderson Cancer Center
  • Highlands Oncology

External person

Benjamin T. Esparaz

  • Decatur Memorial Hospital
  • Central Illinois CCOP
  • Northwestern University
  • Department of Medical Oncology
  • Section of Hematology
  • Heartland Cancer Research NCORP/Cancer Care Specialists of Central Illinois
  • Heartland NCORP

External person

Melissa Kok

  • University of Texas Health Science Center at Houston
  • Baylor College of Medicine

External person

Janelle C. Chavez

  • Stanford University
  • University of Texas Health Science Center at Houston

External person

Jennifer Peterson

  • University of Texas MD Anderson Cancer Center

External person

Andrew Williamson

  • The Christie NHS Foundation Trust

External person

Johnique T. Atkins

  • The University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Program)
  • Department of Anesthesia and Critical Care
  • The University of Chicago
  • Houston Methodist
  • University of Texas Health Science Center at Houston
  • Houston Methodist

External person

S. Z. Fields

  • Duke University Medical Center
  • Arno Therapeutics, Inc.
  • Royal Marsden Hospital London
  • Duke University
  • Departments of Obstetrics
  • Department of Obstetrics
  • Netherlands Cancer Institute
  • Royal Marsden NHS Foundation Trust

External person

Yekaterina B. Khotskaya

  • The University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  • University of Alabama at Birmingham
  • Department of Molecular and Cellular Oncology
  • Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  • Division of Molecular and Cellular Pathology
  • Department of Pathology
  • University of Texas Health Science Center at Houston

External person

Geert Maertens

  • Biocartis NV
  • Biocartis
  • Biocartis Group

External person

Shalini Singh

  • Ventana Medical Systems
  • F. Hoffmann-La Roche AG

External person

Anuj Verma

  • UT MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston
  • Yale New Haven Health System

External person

Oliver Schoor

  • Immatics Biotechnologies
  • Immatics Biotechnologies GmbH

External person

James Lutterbaugh

  • Howard Hughes Medical Institute
  • Case Western Reserve University School of Medicine
  • Case Western Reserve University
  • Case Comprehensive Cancer Center
  • Department of Medicine

External person

J. Bressler

  • Memorial Sloan-Kettering Cancer Center
  • The University of Auckland
  • University of Texas Health Science Center at Houston
  • University of Texas at Austin
  • Division of Epidemiology, Human Genetics, and Environmental Sciences
  • Human Genetics Center
  • Department of Statistics
  • Department of Epidemiology
  • Dept of Epidemiology

External person